Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?

Abdel-Fatah, Tarek and Arora, Arvind and Gorguc, Ipek and Abbotts, Rachel and Beebeejaun, Sarah and Storr, Sarah J. and Mohan, Vivek and Hawkes, Claire and Soomro, Irshad N. and Lobo, Dileep N. and Parsons, Simon L. and Madhusudan, Srinivasan (2013) Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer? Antioxidants & Redox Signaling, 18 (18). pp. 2392-2398. ISSN 1523-0864

[img] PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (518kB)

Abstract

Chronic inflammation is a driving force for gastric carcinogenesis. Reactive oxygen species (ROS) generated during the inflammatory process generates DNA damage that is processed through the DNA repair pathways. In this study, we profiled key DNA repair proteins (single-strand-selective monofunctional uracil-DNA glycosylase 1 [SMUG1], Flap endonuclease 1 [FEN1], X-ray repair cross-complementing gene 1 [XRCC1], and Ataxia telangiectasia mutated [ATM]) involved in ROS-induced oxidative DNA damage repair in gastric cancer and correlated to clinicopathological outcomes. High expression of SMUG1, FEN1, and XRCC1 correlated to high T-stage (T3/T4) (p-values: 0.001, 0.005, and 0.02, respectively). High expression of XRCC1 and FEN1 also correlated to lymph node-positive disease (p-values: 0.009 and 0.02, respectively). High expression of XRCC1, FEN1, and SMUG1 correlated with poor disease-specific survival (DSS) (p-values: 0.001, 0.006, and 0.05, respectively) and poor disease-free survival (DFS) (p-values: 0.001, 0.001, and 0.02, respectively). Low expression of ATM correlated to lymph node positivity (p=0.03), vascular invasion (p=0.05), and perineural invasion (p=0.005) and poor DFS (p=0.001) and poor DSS (p=0.003). In the multivariate Cox model, high XRCC1 and low ATM were independently associated with poor survival (p=0.008 and 0.011, respectively). Our observation supports the hypothesis that DNA repair factors are promising biomarkers for personalized therapy in gastric cancer. Antioxid. Redox Signal. 18, 2392–2398.

Item Type: Article
Additional Information: This is a copy of an article published in Antioxidants & Redox Signaling © 2013 [copyright Mary Ann Liebert, Inc.]; Antioxidants & Redox Signaling is available online at: http://online.liebertpub.com.
Schools/Departments: University of Nottingham UK Campus > Faculty of Medicine and Health Sciences > School of Life Sciences > School of Molecular Medical Sciences
Depositing User: Chamberlain, Mr Dick
Date Deposited: 22 Apr 2014 12:57
Last Modified: 15 Sep 2016 21:10
URI: http://eprints.nottingham.ac.uk/id/eprint/2801

Actions (Archive Staff Only)

Edit View Edit View